These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 15067030)

  • 21. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa.
    Masemola AM; Mashishi TN; Khoury G; Bredell H; Paximadis M; Mathebula T; Barkhan D; Puren A; Vardas E; Colvin M; Zijenah L; Katzenstein D; Musonda R; Allen S; Kumwenda N; Taha T; Gray G; McIntyre J; Karim SA; Sheppard HW; Gray CM;
    J Immunol; 2004 Oct; 173(7):4607-17. PubMed ID: 15383595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
    Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
    PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals.
    Hashimoto M; Kitano M; Honda K; Koizumi H; Dohki S; Oka S; Takiguchi M
    Hum Immunol; 2010 Feb; 71(2):123-7. PubMed ID: 19891998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope.
    Iversen AK; Stewart-Jones G; Learn GH; Christie N; Sylvester-Hviid C; Armitage AE; Kaul R; Beattie T; Lee JK; Li Y; Chotiyarnwong P; Dong T; Xu X; Luscher MA; MacDonald K; Ullum H; Klarlund-Pedersen B; Skinhøj P; Fugger L; Buus S; Mullins JI; Jones EY; van der Merwe PA; McMichael AJ
    Nat Immunol; 2006 Feb; 7(2):179-89. PubMed ID: 16388312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.
    Crawford H; Lumm W; Leslie A; Schaefer M; Boeras D; Prado JG; Tang J; Farmer P; Ndung'u T; Lakhi S; Gilmour J; Goepfert P; Walker BD; Kaslow R; Mulenga J; Allen S; Goulder PJ; Hunter E
    J Exp Med; 2009 Apr; 206(4):909-21. PubMed ID: 19307327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.
    Serwanga J; Nakiboneka R; Mugaba S; Magambo B; Ndembi N; Gotch F; Kaleebu P
    Vaccine; 2015 Mar; 33(14):1664-72. PubMed ID: 25728323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
    Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antiviral efficacy of HIV-specific CD8⁺ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate.
    Ranasinghe SR; Kramer HB; Wright C; Kessler BM; di Gleria K; Zhang Y; Gillespie GM; Blais ME; Culshaw A; Pichulik T; Simmons A; Rowland-Jones SL; McMichael AJ; Dong T
    PLoS Pathog; 2011 May; 7(5):e1001341. PubMed ID: 21589893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection.
    Pillay T; Zhang HT; Drijfhout JW; Robinson N; Brown H; Khan M; Moodley J; Adhikari M; Pfafferott K; Feeney ME; St John A; Holmes EC; Coovadia HM; Klenerman P; Goulder PJ; Phillips RE
    J Virol; 2005 Sep; 79(18):12100-5. PubMed ID: 16140787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-associated immune pressure on Gag protein in CRF01_AE-infected individuals and its association with plasma viral load.
    Gesprasert G; Wichukchinda N; Mori M; Shiino T; Auwanit W; Sriwanthana B; Pathipvanich P; Sawanpanyalert P; Miura T; Auewarakul P; Thitithanyanont A; Ariyoshi K
    PLoS One; 2010 Jun; 5(6):e11179. PubMed ID: 20567513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
    McKinney DM; Lewinsohn DA; Riddell SR; Greenberg PD; Mosier DE
    J Immunol; 1999 Jul; 163(2):861-7. PubMed ID: 10395680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
    Karlsson AC; Iversen AK; Chapman JM; de Oliviera T; Spotts G; McMichael AJ; Davenport MP; Hecht FM; Nixon DF
    PLoS One; 2007 Feb; 2(2):e225. PubMed ID: 17311088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses.
    Yu XG; Shang H; Addo MM; Eldridge RL; Phillips MN; Feeney ME; Strick D; Brander C; Goulder PJ; Rosenberg ES; Walker BD; Altfeld M;
    AIDS; 2002 Feb; 16(3):321-8. PubMed ID: 11834942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Difference in Consensus Sequence between HIV-1 Subtype A/E and Subtype B Viruses on Elicitation of Gag-Specific CD8
    Zhang Y; Murakoshi H; Chikata T; Akahoshi T; Tran GV; Nguyen TV; Gatanaga H; Nguyen KV; Oka S; Kuse N; Takiguchi M
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.
    Tenzer S; Wee E; Burgevin A; Stewart-Jones G; Friis L; Lamberth K; Chang CH; Harndahl M; Weimershaus M; Gerstoft J; Akkad N; Klenerman P; Fugger L; Jones EY; McMichael AJ; Buus S; Schild H; van Endert P; Iversen AK
    Nat Immunol; 2009 Jun; 10(6):636-46. PubMed ID: 19412183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Switching and emergence of CTL epitopes in HIV-1 infection.
    Han C; Kawana-Tachikawa A; Shimizu A; Zhu D; Nakamura H; Adachi E; Kikuchi T; Koga M; Koibuchi T; Gao GF; Sato Y; Yamagata A; Martin E; Fukai S; Brumme ZL; Iwamoto A
    Retrovirology; 2014 May; 11():38. PubMed ID: 24886641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.
    Hay CM; Ruhl DJ; Basgoz NO; Wilson CC; Billingsley JM; DePasquale MP; D'Aquila RT; Wolinsky SM; Crawford JM; Montefiori DC; Walker BD
    J Virol; 1999 Jul; 73(7):5509-19. PubMed ID: 10364299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2, and SIV.
    Gotch F; Nixon D; Gallimore A; McAdam S; McMichael A
    J Med Primatol; 1993; 22(2-3):119-23. PubMed ID: 7692055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.
    Klenerman P; Rowland-Jones S; McAdam S; Edwards J; Daenke S; Lalloo D; Köppe B; Rosenberg W; Boyd D; Edwards A
    Nature; 1994 Jun; 369(6479):403-7. PubMed ID: 7515165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.